HEADER MEMBRANE PROTEIN 07-JAN-20 6VGC TITLE CRYSTAL STRUCTURES OF FLAP BOUND TO DG-031 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5-LIPOXYGENASE-ACTIVATING PROTEIN; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 SYNONYM: FLAP, MK-886-BINDING PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALOX5AP, FLAP; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS 5-LIPOXYGENASE ACTIVATING PROTEIN, FLAP, DG-031, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.D.HO,M.R.LEE,C.T.RAUCH,K.AZNAVOUR,J.S.PARK,J.G.LUZ,S.ANTONYSAMY, AUTHOR 2 B.CONDON,M.MALETIC,A.ZHANG,M.J.HICKEY,N.E.HUGHES,S.CHANDRASEKHAR, AUTHOR 3 A.V.SLOAN,K.GOODING,A.HARVEY,X.P.YU,S.D.KAHL,B.H.NORMAN REVDAT 4 11-OCT-23 6VGC 1 REMARK REVDAT 3 16-DEC-20 6VGC 1 JRNL REVDAT 2 09-DEC-20 6VGC 1 JRNL REVDAT 1 02-DEC-20 6VGC 0 JRNL AUTH J.D.HO,M.R.LEE,C.T.RAUCH,K.AZNAVOUR,J.S.PARK,J.G.LUZ, JRNL AUTH 2 S.ANTONYSAMY,B.CONDON,M.MALETIC,A.ZHANG,M.J.HICKEY, JRNL AUTH 3 N.E.HUGHES,S.CHANDRASEKHAR,A.V.SLOAN,K.GOODING,A.HARVEY, JRNL AUTH 4 X.P.YU,S.D.KAHL,B.H.NORMAN JRNL TITL STRUCTURE-BASED, MULTI-TARGETED DRUG DISCOVERY APPROACH TO JRNL TITL 2 EICOSANOID INHIBITION: DUAL INHIBITORS OF MPGES-1 AND JRNL TITL 3 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP). JRNL REF BIOCHIM BIOPHYS ACTA GEN V.1865 29800 2020 JRNL REF 2 SUBJ JRNL REFN ISSN 1872-8006 JRNL PMID 33246032 JRNL DOI 10.1016/J.BBAGEN.2020.129800 REMARK 2 REMARK 2 RESOLUTION. 2.37 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.37 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 54437 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.255 REMARK 3 R VALUE (WORKING SET) : 0.254 REMARK 3 FREE R VALUE : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2895 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.37 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3982 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.14 REMARK 3 BIN R VALUE (WORKING SET) : 0.3300 REMARK 3 BIN FREE R VALUE SET COUNT : 202 REMARK 3 BIN FREE R VALUE : 0.3640 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7097 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 184 REMARK 3 SOLVENT ATOMS : 59 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.95000 REMARK 3 B22 (A**2) : -0.93000 REMARK 3 B33 (A**2) : -5.51000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.47000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.334 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.255 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.205 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.697 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.910 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7479 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10164 ; 0.817 ; 1.971 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 884 ; 3.399 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 314 ;29.138 ;23.089 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1082 ;14.443 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ; 9.496 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1151 ; 0.052 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5603 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6VGC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB. REMARK 100 THE DEPOSITION ID IS D_1000246339. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-MAY-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 54437 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.370 REMARK 200 RESOLUTION RANGE LOW (A) : 101.490 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04200 REMARK 200 FOR THE DATA SET : 16.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.37 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.40000 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2Q7M REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES PH 6.5, 26% PEG 350 MME, REMARK 280 200 MM CALCIUM CHLORIDE, 1 MM DG-031, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.74400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8260 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22460 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -68.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8040 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -71.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -1 REMARK 465 GLN A 37 REMARK 465 ASN A 38 REMARK 465 GLY A 39 REMARK 465 ARG A 40 REMARK 465 SER A 41 REMARK 465 PHE A 42 REMARK 465 GLN A 43 REMARK 465 ARG A 44 REMARK 465 GLY A 103 REMARK 465 GLU A 104 REMARK 465 ARG A 105 REMARK 465 THR A 106 REMARK 465 GLN A 107 REMARK 465 SER A 108 REMARK 465 THR A 109 REMARK 465 LEU A 159 REMARK 465 ILE A 160 REMARK 465 PRO A 161 REMARK 465 GLU A 162 REMARK 465 GLY A 163 REMARK 465 HIS A 164 REMARK 465 HIS A 165 REMARK 465 HIS A 166 REMARK 465 HIS A 167 REMARK 465 HIS A 168 REMARK 465 HIS A 169 REMARK 465 MET B -1 REMARK 465 ASN B 38 REMARK 465 GLY B 39 REMARK 465 ARG B 40 REMARK 465 GLU B 104 REMARK 465 ARG B 105 REMARK 465 THR B 106 REMARK 465 GLN B 107 REMARK 465 SER B 108 REMARK 465 THR B 109 REMARK 465 LEU B 158 REMARK 465 LEU B 159 REMARK 465 ILE B 160 REMARK 465 PRO B 161 REMARK 465 GLU B 162 REMARK 465 GLY B 163 REMARK 465 HIS B 164 REMARK 465 HIS B 165 REMARK 465 HIS B 166 REMARK 465 HIS B 167 REMARK 465 HIS B 168 REMARK 465 HIS B 169 REMARK 465 MET C -1 REMARK 465 GLN C 37 REMARK 465 ASN C 38 REMARK 465 GLY C 39 REMARK 465 ARG C 40 REMARK 465 GLU C 104 REMARK 465 ARG C 105 REMARK 465 THR C 106 REMARK 465 GLN C 107 REMARK 465 SER C 108 REMARK 465 ILE C 160 REMARK 465 PRO C 161 REMARK 465 GLU C 162 REMARK 465 GLY C 163 REMARK 465 HIS C 164 REMARK 465 HIS C 165 REMARK 465 HIS C 166 REMARK 465 HIS C 167 REMARK 465 HIS C 168 REMARK 465 HIS C 169 REMARK 465 MET D -1 REMARK 465 SER D 0 REMARK 465 GLN D 37 REMARK 465 ASN D 38 REMARK 465 GLY D 39 REMARK 465 ARG D 40 REMARK 465 GLU D 104 REMARK 465 ARG D 105 REMARK 465 THR D 106 REMARK 465 GLY D 163 REMARK 465 HIS D 164 REMARK 465 HIS D 165 REMARK 465 HIS D 166 REMARK 465 HIS D 167 REMARK 465 HIS D 168 REMARK 465 HIS D 169 REMARK 465 MET E -1 REMARK 465 SER E 0 REMARK 465 GLU E 104 REMARK 465 ARG E 105 REMARK 465 THR E 106 REMARK 465 GLN E 107 REMARK 465 SER E 108 REMARK 465 THR E 109 REMARK 465 PRO E 161 REMARK 465 GLU E 162 REMARK 465 GLY E 163 REMARK 465 HIS E 164 REMARK 465 HIS E 165 REMARK 465 HIS E 166 REMARK 465 HIS E 167 REMARK 465 HIS E 168 REMARK 465 HIS E 169 REMARK 465 MET F -1 REMARK 465 SER F 0 REMARK 465 ARG F 35 REMARK 465 THR F 36 REMARK 465 GLN F 37 REMARK 465 ASN F 38 REMARK 465 GLY F 39 REMARK 465 ARG F 40 REMARK 465 SER F 41 REMARK 465 PHE F 42 REMARK 465 GLN F 43 REMARK 465 ARG F 44 REMARK 465 THR F 45 REMARK 465 GLY F 46 REMARK 465 GLU F 104 REMARK 465 ARG F 105 REMARK 465 THR F 106 REMARK 465 GLN F 107 REMARK 465 SER F 108 REMARK 465 THR F 109 REMARK 465 HIS F 167 REMARK 465 HIS F 168 REMARK 465 HIS F 169 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 36 OG1 CG2 REMARK 470 ILE A 154 CG1 CG2 CD1 REMARK 470 LEU A 157 CG CD1 CD2 REMARK 470 SER B 41 OG REMARK 470 GLN B 43 CG CD OE1 NE2 REMARK 470 THR B 45 OG1 CG2 REMARK 470 LEU B 48 CG CD1 CD2 REMARK 470 ARG C 35 CG CD NE CZ NH1 NH2 REMARK 470 SER C 41 OG REMARK 470 GLN D 43 CG CD OE1 NE2 REMARK 470 ARG D 117 CG CD NE CZ NH1 NH2 REMARK 470 LEU F 48 CG CD1 CD2 REMARK 470 ARG F 52 CG CD NE CZ NH1 NH2 REMARK 470 LYS F 96 CG CD CE NZ REMARK 470 VAL F 99 CG1 CG2 REMARK 470 HIS F 164 CG ND1 CD2 CE1 NE2 REMARK 470 HIS F 165 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 78 -77.04 -112.17 REMARK 500 CYS B 78 -88.94 -107.30 REMARK 500 PRO B 156 20.10 -78.28 REMARK 500 CYS C 78 -81.94 -112.41 REMARK 500 CYS D 78 -75.94 -116.20 REMARK 500 CYS E 78 -81.94 -105.71 REMARK 500 LEU F 48 -72.02 56.99 REMARK 500 CYS F 78 -82.74 -110.60 REMARK 500 GLU F 162 173.73 63.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 202 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLN A 58 OE1 REMARK 620 2 ASP A 62 OD1 67.6 REMARK 620 3 GLN B 58 OE1 77.5 133.8 REMARK 620 4 GLN C 58 OE1 68.8 62.8 77.1 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA D 202 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLN D 58 OE1 REMARK 620 2 GLN E 58 OE1 100.7 REMARK 620 3 GLN F 58 OE1 82.9 76.3 REMARK 620 4 ASP F 62 OD1 75.4 158.5 82.1 REMARK 620 N 1 2 3 DBREF 6VGC A 2 161 UNP P20292 AL5AP_HUMAN 2 161 DBREF 6VGC B 2 161 UNP P20292 AL5AP_HUMAN 2 161 DBREF 6VGC C 2 161 UNP P20292 AL5AP_HUMAN 2 161 DBREF 6VGC D 2 161 UNP P20292 AL5AP_HUMAN 2 161 DBREF 6VGC E 2 161 UNP P20292 AL5AP_HUMAN 2 161 DBREF 6VGC F 2 161 UNP P20292 AL5AP_HUMAN 2 161 SEQADV 6VGC MET A -1 UNP P20292 INITIATING METHIONINE SEQADV 6VGC SER A 0 UNP P20292 EXPRESSION TAG SEQADV 6VGC LEU A 1 UNP P20292 EXPRESSION TAG SEQADV 6VGC ALA A 148 UNP P20292 LYS 148 CONFLICT SEQADV 6VGC GLU A 162 UNP P20292 EXPRESSION TAG SEQADV 6VGC GLY A 163 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS A 164 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS A 165 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS A 166 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS A 167 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS A 168 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS A 169 UNP P20292 EXPRESSION TAG SEQADV 6VGC MET B -1 UNP P20292 INITIATING METHIONINE SEQADV 6VGC SER B 0 UNP P20292 EXPRESSION TAG SEQADV 6VGC LEU B 1 UNP P20292 EXPRESSION TAG SEQADV 6VGC ALA B 148 UNP P20292 LYS 148 CONFLICT SEQADV 6VGC GLU B 162 UNP P20292 EXPRESSION TAG SEQADV 6VGC GLY B 163 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS B 164 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS B 165 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS B 166 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS B 167 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS B 168 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS B 169 UNP P20292 EXPRESSION TAG SEQADV 6VGC MET C -1 UNP P20292 INITIATING METHIONINE SEQADV 6VGC SER C 0 UNP P20292 EXPRESSION TAG SEQADV 6VGC LEU C 1 UNP P20292 EXPRESSION TAG SEQADV 6VGC ALA C 148 UNP P20292 LYS 148 CONFLICT SEQADV 6VGC GLU C 162 UNP P20292 EXPRESSION TAG SEQADV 6VGC GLY C 163 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS C 164 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS C 165 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS C 166 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS C 167 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS C 168 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS C 169 UNP P20292 EXPRESSION TAG SEQADV 6VGC MET D -1 UNP P20292 INITIATING METHIONINE SEQADV 6VGC SER D 0 UNP P20292 EXPRESSION TAG SEQADV 6VGC LEU D 1 UNP P20292 EXPRESSION TAG SEQADV 6VGC ALA D 148 UNP P20292 LYS 148 CONFLICT SEQADV 6VGC GLU D 162 UNP P20292 EXPRESSION TAG SEQADV 6VGC GLY D 163 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS D 164 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS D 165 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS D 166 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS D 167 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS D 168 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS D 169 UNP P20292 EXPRESSION TAG SEQADV 6VGC MET E -1 UNP P20292 INITIATING METHIONINE SEQADV 6VGC SER E 0 UNP P20292 EXPRESSION TAG SEQADV 6VGC LEU E 1 UNP P20292 EXPRESSION TAG SEQADV 6VGC ALA E 148 UNP P20292 LYS 148 CONFLICT SEQADV 6VGC GLU E 162 UNP P20292 EXPRESSION TAG SEQADV 6VGC GLY E 163 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS E 164 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS E 165 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS E 166 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS E 167 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS E 168 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS E 169 UNP P20292 EXPRESSION TAG SEQADV 6VGC MET F -1 UNP P20292 INITIATING METHIONINE SEQADV 6VGC SER F 0 UNP P20292 EXPRESSION TAG SEQADV 6VGC LEU F 1 UNP P20292 EXPRESSION TAG SEQADV 6VGC ALA F 148 UNP P20292 LYS 148 CONFLICT SEQADV 6VGC GLU F 162 UNP P20292 EXPRESSION TAG SEQADV 6VGC GLY F 163 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS F 164 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS F 165 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS F 166 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS F 167 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS F 168 UNP P20292 EXPRESSION TAG SEQADV 6VGC HIS F 169 UNP P20292 EXPRESSION TAG SEQRES 1 A 171 MET SER LEU ASP GLN GLU THR VAL GLY ASN VAL VAL LEU SEQRES 2 A 171 LEU ALA ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY SEQRES 3 A 171 PHE PHE ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN SEQRES 4 A 171 ASN GLY ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE SEQRES 5 A 171 GLU ARG VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA SEQRES 6 A 171 TYR PRO THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU SEQRES 7 A 171 LEU CYS SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MET SEQRES 8 A 171 TYR LEU PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU SEQRES 9 A 171 GLY GLU ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY SEQRES 10 A 171 LYS ARG ILE ILE LEU PHE LEU PHE LEU MET SER VAL ALA SEQRES 11 A 171 GLY ILE PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER SEQRES 12 A 171 ASP PHE GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SEQRES 13 A 171 SER PRO LEU LEU LEU ILE PRO GLU GLY HIS HIS HIS HIS SEQRES 14 A 171 HIS HIS SEQRES 1 B 171 MET SER LEU ASP GLN GLU THR VAL GLY ASN VAL VAL LEU SEQRES 2 B 171 LEU ALA ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY SEQRES 3 B 171 PHE PHE ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN SEQRES 4 B 171 ASN GLY ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE SEQRES 5 B 171 GLU ARG VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA SEQRES 6 B 171 TYR PRO THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU SEQRES 7 B 171 LEU CYS SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MET SEQRES 8 B 171 TYR LEU PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU SEQRES 9 B 171 GLY GLU ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY SEQRES 10 B 171 LYS ARG ILE ILE LEU PHE LEU PHE LEU MET SER VAL ALA SEQRES 11 B 171 GLY ILE PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER SEQRES 12 B 171 ASP PHE GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SEQRES 13 B 171 SER PRO LEU LEU LEU ILE PRO GLU GLY HIS HIS HIS HIS SEQRES 14 B 171 HIS HIS SEQRES 1 C 171 MET SER LEU ASP GLN GLU THR VAL GLY ASN VAL VAL LEU SEQRES 2 C 171 LEU ALA ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY SEQRES 3 C 171 PHE PHE ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN SEQRES 4 C 171 ASN GLY ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE SEQRES 5 C 171 GLU ARG VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA SEQRES 6 C 171 TYR PRO THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU SEQRES 7 C 171 LEU CYS SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MET SEQRES 8 C 171 TYR LEU PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU SEQRES 9 C 171 GLY GLU ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY SEQRES 10 C 171 LYS ARG ILE ILE LEU PHE LEU PHE LEU MET SER VAL ALA SEQRES 11 C 171 GLY ILE PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER SEQRES 12 C 171 ASP PHE GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SEQRES 13 C 171 SER PRO LEU LEU LEU ILE PRO GLU GLY HIS HIS HIS HIS SEQRES 14 C 171 HIS HIS SEQRES 1 D 171 MET SER LEU ASP GLN GLU THR VAL GLY ASN VAL VAL LEU SEQRES 2 D 171 LEU ALA ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY SEQRES 3 D 171 PHE PHE ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN SEQRES 4 D 171 ASN GLY ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE SEQRES 5 D 171 GLU ARG VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA SEQRES 6 D 171 TYR PRO THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU SEQRES 7 D 171 LEU CYS SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MET SEQRES 8 D 171 TYR LEU PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU SEQRES 9 D 171 GLY GLU ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY SEQRES 10 D 171 LYS ARG ILE ILE LEU PHE LEU PHE LEU MET SER VAL ALA SEQRES 11 D 171 GLY ILE PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER SEQRES 12 D 171 ASP PHE GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SEQRES 13 D 171 SER PRO LEU LEU LEU ILE PRO GLU GLY HIS HIS HIS HIS SEQRES 14 D 171 HIS HIS SEQRES 1 E 171 MET SER LEU ASP GLN GLU THR VAL GLY ASN VAL VAL LEU SEQRES 2 E 171 LEU ALA ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY SEQRES 3 E 171 PHE PHE ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN SEQRES 4 E 171 ASN GLY ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE SEQRES 5 E 171 GLU ARG VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA SEQRES 6 E 171 TYR PRO THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU SEQRES 7 E 171 LEU CYS SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MET SEQRES 8 E 171 TYR LEU PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU SEQRES 9 E 171 GLY GLU ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY SEQRES 10 E 171 LYS ARG ILE ILE LEU PHE LEU PHE LEU MET SER VAL ALA SEQRES 11 E 171 GLY ILE PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER SEQRES 12 E 171 ASP PHE GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SEQRES 13 E 171 SER PRO LEU LEU LEU ILE PRO GLU GLY HIS HIS HIS HIS SEQRES 14 E 171 HIS HIS SEQRES 1 F 171 MET SER LEU ASP GLN GLU THR VAL GLY ASN VAL VAL LEU SEQRES 2 F 171 LEU ALA ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY SEQRES 3 F 171 PHE PHE ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN SEQRES 4 F 171 ASN GLY ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE SEQRES 5 F 171 GLU ARG VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA SEQRES 6 F 171 TYR PRO THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU SEQRES 7 F 171 LEU CYS SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MET SEQRES 8 F 171 TYR LEU PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU SEQRES 9 F 171 GLY GLU ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY SEQRES 10 F 171 LYS ARG ILE ILE LEU PHE LEU PHE LEU MET SER VAL ALA SEQRES 11 F 171 GLY ILE PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER SEQRES 12 F 171 ASP PHE GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SEQRES 13 F 171 SER PRO LEU LEU LEU ILE PRO GLU GLY HIS HIS HIS HIS SEQRES 14 F 171 HIS HIS HET QY1 A 201 27 HET QY1 B 201 27 HET CA B 202 1 HET QY1 C 201 27 HET QY1 D 201 27 HET CA D 202 1 HET QY1 E 201 27 HET QY1 F 201 27 HET BOG F 202 20 HETNAM QY1 (2R)-CYCLOPENTYL{4-[(QUINOLIN-2-YL) HETNAM 2 QY1 METHOXY]PHENYL}ACETIC ACID HETNAM CA CALCIUM ION HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D- HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE FORMUL 7 QY1 6(C23 H23 N O3) FORMUL 9 CA 2(CA 2+) FORMUL 15 BOG C14 H28 O6 FORMUL 16 HOH *59(H2 O) HELIX 1 AA1 ASP A 2 ASN A 8 1 7 HELIX 2 AA2 VAL A 9 ARG A 35 1 27 HELIX 3 AA3 THR A 47 CYS A 78 1 32 HELIX 4 AA4 SER A 79 LEU A 102 1 24 HELIX 5 AA5 GLY A 115 ILE A 154 1 40 HELIX 6 AA6 ASP B 2 ASN B 8 1 7 HELIX 7 AA7 VAL B 9 ARG B 35 1 27 HELIX 8 AA8 THR B 47 CYS B 78 1 32 HELIX 9 AA9 SER B 79 GLY B 103 1 25 HELIX 10 AB1 GLY B 115 SER B 155 1 41 HELIX 11 AB2 ASP C 2 GLY C 7 1 6 HELIX 12 AB3 VAL C 9 ARG C 35 1 27 HELIX 13 AB4 THR C 47 CYS C 78 1 32 HELIX 14 AB5 SER C 79 LEU C 102 1 24 HELIX 15 AB6 GLY C 115 ILE C 154 1 40 HELIX 16 AB7 ASP D 2 THR D 36 1 35 HELIX 17 AB8 THR D 47 CYS D 78 1 32 HELIX 18 AB9 SER D 79 GLY D 100 1 22 HELIX 19 AC1 GLY D 115 LEU D 159 1 45 HELIX 20 AC2 ASP E 2 GLN E 37 1 36 HELIX 21 AC3 THR E 47 CYS E 78 1 32 HELIX 22 AC4 SER E 79 GLY E 103 1 25 HELIX 23 AC5 GLY E 115 LEU E 159 1 45 HELIX 24 AC6 ASP F 2 ASN F 8 1 7 HELIX 25 AC7 VAL F 9 SER F 34 1 26 HELIX 26 AC8 LEU F 48 CYS F 78 1 31 HELIX 27 AC9 SER F 79 GLY F 103 1 25 HELIX 28 AD1 GLY F 115 SER F 155 1 41 HELIX 29 AD2 PRO F 156 ILE F 160 5 5 LINK OE1 GLN A 58 CA CA B 202 1555 1555 2.36 LINK OD1 ASP A 62 CA CA B 202 1555 1555 3.11 LINK OE1 GLN B 58 CA CA B 202 1555 1555 2.31 LINK CA CA B 202 OE1 GLN C 58 1555 1555 2.43 LINK OE1 GLN D 58 CA CA D 202 1555 1555 2.36 LINK CA CA D 202 OE1 GLN E 58 1555 1555 2.37 LINK CA CA D 202 OE1 GLN F 58 1555 1555 2.30 LINK CA CA D 202 OD1 ASP F 62 1555 1555 2.55 CISPEP 1 PRO F 110 GLY F 111 0 -0.23 CRYST1 65.911 101.488 111.864 90.00 99.83 90.00 P 1 21 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015172 0.000000 0.002629 0.00000 SCALE2 0.000000 0.009853 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009073 0.00000